Gyre Therapeutics, Inc. (GYRE) Reports Q2 EPS of $0.01
Tweet
Share
E-mailGet Alerts GYRE Hot Sheet
Join SI Premium – FREE
Gyre Therapeutics, Inc. (NASDAQ: GYRE) reported Q2 EPS of $0.01, versus $0.02 reported last year. Revenue for the quarter came in at $25.2 million, versus $29.33 million reported last year.
For earnings history and earnings-related data on Gyre Therapeutics, Inc. (GYRE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- lululemon athletica (LULU) call put ratio 1 call to 1 put into quarter results
- Ciena beats estimates on strong AI-driven demand, shares rise
- Genesco (GCO) Tops Q2 EPS by 54c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
